Hoskins JM - Search Results

1

UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, McLeod HL. Hoskins JM, et al. J Natl Cancer Inst. 2007 Sep 5;99(17):1290-5. doi: 10.1093/jnci/djm115. Epub 2007 Aug 28. J Natl Cancer Inst. 2007. PMID: 17728214

2

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.

Thomas F, Motsinger-Reif AA, Hoskins JM, Dvorak A, Roy S, Alyasiri A, Myerson RJ, Fleshman JW, Tan BR, McLeod HL. Thomas F, et al. Among authors: hoskins jm. Br J Cancer. 2011 Nov 22;105(11):1654-62. doi: 10.1038/bjc.2011.442. Epub 2011 Nov 1. Br J Cancer. 2011. PMID: 22045187 Free PMC article. Clinical Trial.

3

Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.

Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Hoskins JM, et al. Pharmacogenomics. 2009 Jul;10(7):1139-46. doi: 10.2217/pgs.09.35. Pharmacogenomics. 2009. PMID: 19604089 Free PMC article.

4

CYP2D6 and tamoxifen: DNA matters in breast cancer.

Hoskins JM, Carey LA, McLeod HL. Hoskins JM, et al. Nat Rev Cancer. 2009 Aug;9(8):576-86. doi: 10.1038/nrc2683. Nat Rev Cancer. 2009. PMID: 19629072 Review.

5

Irinotecan pharmacogenetics: influence of pharmacodynamic genes.

Hoskins JM, Marcuello E, Altes A, Marsh S, Maxwell T, Van Booven DJ, Paré L, Culverhouse R, McLeod HL, Baiget M. Hoskins JM, et al. Clin Cancer Res. 2008 Mar 15;14(6):1788-96. doi: 10.1158/1078-0432.CCR-07-1472. Clin Cancer Res. 2008. PMID: 18347181

6

UGT1A and irinotecan toxicity: keeping it in the family.

Hoskins JM, McLeod HL. Hoskins JM, et al. J Clin Oncol. 2009 May 20;27(15):2419-21. doi: 10.1200/JCO.2008.20.9478. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364959 No abstract available.

7

Pharmacogenetics of breast cancer therapies.

Hertz DL, McLeod HL, Hoskins JM. Hertz DL, et al. Among authors: hoskins jm. Breast. 2009 Oct;18 Suppl 3:S59-63. doi: 10.1016/S0960-9776(09)70275-9. Breast. 2009. PMID: 19914545 Free article. Review.

8

Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial.

He YJ, Winham SJ, Hoskins JM, Glass S, Paul J, Brown R, Motsinger-Reif A, McLeod HL. He YJ, et al. Among authors: hoskins jm. Pharmacogenomics J. 2016 Jun;16(3):243-8. doi: 10.1038/tpj.2015.52. Epub 2015 Jul 21. Pharmacogenomics J. 2016. PMID: 26194361 Free article. Clinical Trial.

9

Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.

Rakhra-Burris TK, Auman JT, Deverka P, Dressler LG, Evans JP, Goldberg RM, Havener TM, Hoskins JM, Jonas DE, Long KM, Motsinger-Reif AA, Irvin WJ, Richards KL, Roederer MW, Valgus JM, Riper Mv, Vernon JA, Zamboni WC, Wagner MJ, Walko CM, Weck KE, Wiltshire T, McLeod HL. Rakhra-Burris TK, et al. Among authors: hoskins jm. Pharmacogenomics. 2010 Jan;11(1):13-21. doi: 10.2217/pgs.09.167. Pharmacogenomics. 2010. PMID: 20017668

10

Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy.

Watson RG, Muhale F, Thorne LB, Yu J, O'Neil BH, Hoskins JM, Meyers MO, Deal AM, Ibrahim JG, Hudson ML, Walko CM, McLeod HL, Auman JT. Watson RG, et al. Among authors: hoskins jm. Eur J Cancer. 2010 Dec;46(18):3358-64. doi: 10.1016/j.ejca.2010.07.011. Epub 2010 Aug 18. Eur J Cancer. 2010. PMID: 20727737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters